Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

• Published in: Pediatrics (Evanston) 2018-01, Vol.141 (1)
• Main Authors: Hofstetter, Annika M, Lacombe, Kirsten, Klein, Eileen J, Jones, Charla, Strelitz, Bonnie, Jacobson, Elizabeth, Ranade, Daksha, Ward, M Leanne, Mijatovic-Rustempasic, Slavica, Evans, Diana, Wikswo, Mary, Bowen, Michael D, Parashar, Umesh D, Payne, Daniel C, Englund, Janet A
• Format: Article
• Language: English
• Subjects: Academic Medical Centers; Cohort Studies; Cross Infection - epidemiology; Cross Infection - prevention & control; Female; Health aspects; Hospitalization - statistics & numerical data; Humans; Infant; Infant, Newborn; Infant, Premature; Infants (Premature); Intensive Care Units, Neonatal; Male; Patient Discharge; Premature infants; Prospective Studies; Risk Assessment; Risk factors; Rotavirus - immunology; Rotavirus - isolation & purification; Rotavirus infections; Rotavirus Infections - prevention & control; Rotavirus Vaccines - administration & dosage; Time Factors; United States; Vaccination - standards; Vaccination - trends
• ISSN: 0031-4005; 1098-4275
• DOI: 10.1542/peds.2017-1110

Infants born prematurely or with underlying conditions are at increased risk of severe rotavirus disease and associated complications. Given the theoretical risk of nosocomial transmission of vaccine-type rotavirus, rotavirus vaccination is recommended for infants at or after discharge from neonatal care settings. Because the first dose should be administered by 104 days of age, some infants may be age-ineligible for vaccination if delayed until discharge. This prospective cohort included infants admitted to an urban academic medical center between birth and 104 days who received care in intensive care settings. Pentavalent human-bovine reassortant rotavirus vaccine (RV5) was used, per routine clinical care. Stool specimens were collected weekly (February 2013-April 2014) and analyzed for rotavirus strains using real-time reverse transcription-polymerase chain reaction. Demographic and vaccine data were collected. RV5 safety was not assessed. Of 385 study infants, 127 were age-eligible for routine vaccinations during hospitalization. At discharge, 32.7% were up-to-date for rotavirus vaccination, compared with 82.7% for other vaccinations. Of rotavirus-unvaccinated infants, 42.6% were discharged at age >104 days and thus vaccination-ineligible. Of 1192 stool specimens collected, rotavirus was detected in 13 (1.1%): 1 wild-type strain from an unvaccinated infant; 12 vaccine-type strains from 9 RV5-vaccinated infants. No vaccine-type rotavirus cases were observed among unvaccinated infants (incidence rate: 0.0 [95% confidence interval: 0.0-1.5] cases per 1000 patient days at risk). These data suggest that delaying rotavirus vaccination until discharge from the hospital could lead to missed vaccination opportunities and may be unnecessary in institutions using RV5 with comparable infection control standards.